{"id":"NCT00960141","sponsor":"Organon and Co","briefTitle":"A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)","officialTitle":"A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effect of Montelukast in Patients With Seasonal Allergic Rhinitis-Fall Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-08","primaryCompletion":"2000-10","completion":"2000-11","firstPosted":"2009-08-17","resultsPosted":"2010-06-09","lastUpdate":"2022-02-03"},"enrollment":829,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"montelukast sodium","otherNames":[]},{"type":"DRUG","name":"Comparator: loratadine","otherNames":[]},{"type":"DRUG","name":"Comparator: placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"PLACEBO_COMPARATOR"}],"summary":"A study of the ability of montelukast to improve signs and symptoms of seasonal allergic rhinitis compared with placebo. Loratadine is included in the study as an active control.","primaryOutcome":{"measure":"Mean Change From Baseline in Daytime Nasal Symptoms Score","timeFrame":"Baseline and Week 2","effectByArm":[{"arm":"Placebo","deltaMin":-0.32,"sd":null},{"arm":"Montelukast","deltaMin":-0.38,"sd":null},{"arm":"Loratadine","deltaMin":-0.47,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["15049402"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":333},"commonTop":["Headache"]}}